Most people do not recognize cancer warning signs
the ONA take:
According to a new study published in the journal PLOS ONE, most people ignore cancer "alarm" symptoms. Researchers at University College London in London, United Kingdom, asked 1,724 participants aged 50 years and over whether they had experienced and of 17 cancer "alarm" symptoms.
Some symptoms included in the questionnaire were changes in mole appearance, difficulty swallowing, persistent change in bowel habits, unexplained bleeding, unexplained cough, unexplained lumps, and unexplained weight loss. Participants were not informed as to which symptoms are warning signs of cancer.
They were asked what they the thought to be the cause of any symptoms they experienced, as well as how serious they deemed the symptoms to be and if they visited the doctor as a result.
Of all respondents of the questionnaire, 53% reported experiencing at least one cancer warning symptom in the last 3 months and only 2% considered the warning symptoms to be cancer-related. Persistent cough and persistent change in bowel habits were the most common cancer warning signs experienced; unexplained weight loss and difficulty swallowing were the least.
Results showed that 59% of participants who experienced cancer signs visited a doctor. The findings suggest that many people who experience cancer signs do not realize the seriousness of their symptoms.
Most people ignore cancer "alarm" symptoms.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|